{
  "ticker": "NUZ",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02974279",
  "id": "02974279",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250730",
  "time": "0910",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250730/pdf/06m9b36pg20w7c.pdf",
  "summary": "### Summary of ASX Announcement:  \n\n- **Loan Agreement**: Secured $1.5m loan from Radium Capital against a portion of the expected **2025 R&D Tax Rebate** (\u226430% of total rebate).  \n- **Non-Dilutive Financing**: Interest rate of **17% p.a.**, repayable from the 2025 rebate proceeds. Enhances liquidity without equity dilution.  \n- **Cash Position**: Closing cash balance as of **30 June 2025: $4.161m** (unaudited).  \n- **Purpose**: Funds to sustain operational momentum and advance pipeline (e.g., ALS drug candidate NUZ-001).  \n\n*No other material information identified.*",
  "usage": {
    "prompt_tokens": 1174,
    "completion_tokens": 150,
    "total_tokens": 1324,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-29T23:27:16.893632"
}